These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24563233)
1. Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study. Novak Kujundžić R; Grbeša I; Ivkić M; Krušlin B; Konjevoda P; Gall Trošelj K Pathol Oncol Res; 2014 Jul; 20(3):687-95. PubMed ID: 24563233 [TBL] [Abstract][Full Text] [Related]
2. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795 [TBL] [Abstract][Full Text] [Related]
3. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer. Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251 [TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813 [TBL] [Abstract][Full Text] [Related]
5. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas. Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139 [TBL] [Abstract][Full Text] [Related]
6. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma. de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma. Zhang H; Chen W; Duan CJ; Zhang CF World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267 [TBL] [Abstract][Full Text] [Related]
8. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma. Foteinou E; Kontos CK; Giotakis AI; Scorilas A Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539 [TBL] [Abstract][Full Text] [Related]
9. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis. Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432 [TBL] [Abstract][Full Text] [Related]
10. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. Mao Y; Zhang DW; Lin H; Xiong L; Liu Y; Li QD; Ma J; Cao Q; Chen RJ; Zhu J; Feng ZQ J Exp Clin Cancer Res; 2012 Dec; 31(1):101. PubMed ID: 23231769 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma. Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151 [TBL] [Abstract][Full Text] [Related]
12. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Okabayashi K; Fujita T; Miyazaki J; Okada T; Iwata T; Hirao N; Noji S; Tsukamoto N; Goshima N; Hasegawa H; Takeuchi H; Ueda M; Kitagawa Y; Kawakami Y Cancer Sci; 2012 Sep; 103(9):1617-24. PubMed ID: 22676270 [TBL] [Abstract][Full Text] [Related]
19. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]